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FREQUENCY OF FAB SUBTYPES IN ACUTE MYELOID LEUKE:\11A
PATIENTS AT AGA KHAN UNIVERSITY HOSPITAL KARACHI
Mahadev S. Harani, Salman Naseem Adil, Mohammad l!sman Shaikh,
Ghulam Nabi Kakepoto, Mohammmad Khurshid,
lkpartmcnl Of

P~1tholo11,y

& :\licrollinlogy, .-\.ga 1\.h:tn

L'ni\CL\il~. h.<tr~rchi

Background: Acute myeloid leukemia (/\fv·IL) is a heterogeneous di~ca-;c. Then:fmc, vannus
parnmctcrs are needed to classify this disease into .-;ubtypcs, so that spcci1ic tn.·atlllcnt approaches
can be utilized effcctiH~Iy. The commonly used methud for diagnosi.c; and classification is based
on fAR criteria using morphology and cytochemical st<lins. For .c;omc or the categories,
imllll!llOphcnotyping is llCCCSS<lry. The aim of present study is to determine the llTqucncy or
various sub typ.:s in acute myeloid lcukcr11i<:l using Fr\11 criteria in our popul:1tion. Thi~ \\ il! aid in
the COrrect diagnosiS Of '-!CUte k·ukt:ll1ia and hellCl' proper lllilllagC!l1l'!lt or !ilL' p:llit:llh. i\lateriab
and \lrthuds: This is dc~cripti\'e case control :>tudy concluctcd at :\ga Khan Lni\·u·.;ity llnspital
from January 1999 to DcccmbL'r 2000. The tnt<~! number of subject;, \\'ilS II() that included both
adults and children. The patienis were diugnnsed on the basis or bone m:1rrow morphology using
rAB cbssification. Cytochemistry was done in all cases, while immunophcnotyping \\·as
considered only in tho~l' case~ that were fouml to be problematic. Results: Among 110 patients.
70 \\ crL' males and 46 \\ere females \\ ith male tn fclllale ratio 1.5: I. ['he age ranged between 6
months to S.5 ye~1rs with a mean age or 32 ycms . .-\ML-M4 was the prL·dominant r:rcncht\nlL'ric:ul-British (FA]{) subt.ype {:-;6 ..2 1:/;1) followed by J\.1.2 (:l0 ..2Y;<1). J\.1) { l 0.4°/;i). !'vii (S.7'>(1). :-...w
(7 7" o), !viSa (3.5°--(i), i\·15b (.2S~--o) <lnd \16 (O.S 01(1). Conclusions: The 1110'-;t C0111lllO!l J.".,\B suhtypL'
ob.-.,crvcd in our .study was !\cute myelon10nocytic leukemia {M4) which i~ in accordance \\ith
studies reported Jl·om Snudia Arabia and a previous study reported from our Institution.
However,othcr ll<ltional and international studies have reported Myelobl;tstic Leukemia \\·ith
matur<ltion ( M:2) as the prl'dominant subtyp: of AML.
Kcy,,ords: Frcnch-,\merican-British (1-"l\B) cla ...,sification. Acute myL·Ioid Leukemic! (AML).
subtypes.
degree or matllration of the leukemic cell." and their
lineage diffl:rcntiation. The major ad\·antagc of the
FAB cb~sifieation :-.ystem is its case of usc. The
cytological criteria arc \vcll defined: they· do not
require high technology and Cdll be appliec1 in 1110:-:,t
htboratories through out the \\Orld "Keeping i11 \ ie\'
these ad\'antagcs, the FAB proposal \\·as ~nlopkd
intcrnmion<llly. It pro\ !lied long needed ..,umcbrd
terminology and wa:-, qurckly acccrted by most of the
multi-institutional stu<l~ groups for llldll<lgemcnt
[llans and CO!llp<.trison of treatment results het\\'l"Cll
morphologic
subtypes
for
their
prog:nostil.'
significance.
Present study was done to determine the
frequency of AML tyres in our populatio11 . .-\c; the
patients were tl·om all over Pakist<m bclong1n); to
various ethnic groups, our study thus well repn:~cnt
AML subtypes of the entire country.
Altllough. it is a single institution based
study, the number of cases studied is largest that i..;
ever reported at national level. Hence. our '::itudy
tends to establish <1 trend or J\ML subtypes in
Pakistan.

INTRODLCTIOI\"
Acute myeloid Lcukemi<l is a heterogeneous disease.
Thercrore parameters arc needed to cb ...,sify thi;,
disease into hio!ogic entities to understand its
pclthogencsis
and
dcYelop
spcciftc
treatment
approaches.~_ ·' :\s therapeutic <ldvanccs \\'Cre made,
distinguishing the subtypes of acute leukemia became
inen.:asingly in1portant.
.Acute leukemias are cbs ...,i!icd on the basis
of the presumed cell of origin. Concordance between
experienced observers in the classification or acute
leukemia mcreases from 70 to 99<;~1 when
morphologic
criteria
are
supplemented
by
cytochemical and immunphenotypic information.-'
The modern era for clas~irication or acute
leukemias dme.'-' back to !976. when intcrnation~J!
group of investigators from France, America and
Britain dcv eloped a uniform c lassitlcation system
designated
as
French-American-British
(FAB)
clas~ification-1, which was subsequently revised in
!9R5.'
The FJ\B classification of J\ML di\ ides
cases into eight major groups with subtyTJCs ror three
of them (table I). The classification criteria arc based
011 morrhologic and cytochemical feawrcs: hovvever
for .',OillC or the Categories, illllllH!lOp!lellOtyping is
7
It is lineage-based morphological
ntcessary.(,,
classi !lcation that categorizes cases according to the

MATERIAL AND METHODS
This is descriptive case-control study done at
hematology department of Agc1 Khan University
Hospital. This is <1 tertiary care hospital receiving

26
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c<tc-e:-; from all over 1hc country. The study was
cnnduc!ed oYer a period of 2 years from January

AML was elassiried into its various subtypes. (IV10M7) using FAH criteria. (Tablc-l)s cl-hc p1-escnce or
absence of Aucr rod in each bone marrow film was
also noted.

19_99 to 1kccmbcr 2000.

Patients
\\"ith
history
of
pre\"lous
hcmatnlogictl disorders like myelodysplasia, CML.
;Jpb.c;tic anaemia and \\·ith hi.c;tory prior chemotherapy
ur r<ldiothL·rapy \\t.:'rc cxcludL·d from the :-.tudy. The
p;tticnts who were knuwn cases or A ML \\·ith or
\\ ithuut trc;Jtment including relapsed case.'-' \vcrc also

RESULTS
Qj' ]](--, CaSeS. 70 \\CrL' lllJlC.<; and 40 \\TI"L' felllalcs
with male to female ratio 1.5: l. The mean age w:Jc; 32
years (range 6 months RS years). 21 cases were up
to the age of l5ycar~ comprising or 17 !lla\cs and 4
female~ nnd their ag~..· range:~ between 6 month_..,_ 1)
yem:>. Their hacmatolugical parameters arc gin::n in
table :Z. The CHC shmYed a \\'ide range of variation in
hemoglobin concentration and platelets ranging from
~ubnormal to normal. Their Ltukocyte count ;_Jlso
shm\ed vamttion from leucorenia t(l hyper
leukocytosis.
In our study. \\'e found AML (M4 FAB
suhtypt,;s) to be the C"(lllll110ncst comrrising •-J.:z out of
ll (J of' total cases (36.15%). This abo included 6
C<.lse:--. of M4 Eo variant. The frequency of various
AML subtypes according to FAR classification is
given in Figure 1.
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Based on this. a told] or l\6 suhjech with
llC\\·ly diagno~ed untreated denovc AM L were
inl"ludcd in the study. It included paticnb o!' all age
gnHtps and both -.;c\.c ...,
The dic1gno...,i.s or .-\_\1L \\·a:-. established
;JL'(mding to the stancLmi practicL'. and was h~hcd on
]Kriphera! blood <md bone marrow morphology and

Figure 1: French -American-British (I A. B) Sub
types in 116 cases of A\1 L

cytochcmi-;rry. !mmunophcnotyping \\i.b done where
con:--.idcrcll essential. I lcmatological lXlramctL-rs \\ere
dom' on Coulter counter (model stak-:-,J_
Bone marrcl\\ <:bpirntion \\'<-lS done from
pn<-;~cnm ilii.tC crc:-.t. A wrillcn consent w~1s taken
!"rom patients or parents as appropriate. In C\Try Glse,
h-S smcar_c; \\CI'L' nwdc: t\\0 of them \\ ith peripheral
c;nll'<tr.c; were stained by· Leishman·~ stain. In addition
Cullowing cytochemical stains were carried out on
flcriphcral blood and bone marrow smears in each
case: Sudan black!~ (SBB). periodic acid-Schiff
(PAS). myelopcroxidase (Ml'O) and alpha naphthyl
<!Cetak esterase (ANAE) by commercially provided
kits
!i·o111
Sigm<~
Diagnostic
ac-cordin_g
to
m~lllll !':tcturcr · s
illstrttctinllS. Inln1ttnophenotyping
\\ :Lc; carried out in :-,omc pctticnb \Vith diagno~tic
dilliculties and \\'tb performed hy 2 color flO\\
cytomctric anal_y'sis of hone marrow aspirak m

The cases were further dividc:d in adult and
children group. Both groups- ren:alcd M4 as <l most
FAB type follO\\"ed by M2. Relative
frequencies of V<JriOUS S-Ubtypes !(lr adults and
children arc illustrated in Table 3.
common

Aucr rods were present in 36.:2. {;..q 42 cases).
They \\-'ere more common in \-13 subtype (9/12. 75~/[))

peripheral blood specimens with a Becton Dickinson

followed hy M2 (I X;35, 51 A'X,), M4 I \2;42, 2X 5%),

l\·lount<1in \'iew. Cal·if) L\C Scan instrument. Arter
nlOllUnuclcacr cell enrichment by centrifugation O\'cr
J !i.c;tnpaquc-1077 (Sigm<L St.
Louis Vlo), samples
\\ C1"C :--.tudicd for sudi1cc c1111igen cxpre:'ision u.sing a
panL·l of 15 monoclonal antibodies supplied by
(Ike ton Dickinson, San Jose, Calif and Dako

Ml (2/10, 20%) and .\15 (L. 7, 14.2(.%).Thc number of
Aucr rods per cell was consistently grcate1 in lvB
subtype. No Auer rods were observed in the ~·!() or
M6 subtype.

Tahle-2: Haematological parameter~ in A!VIL
patients (n ~ 116)

!kn111;1rk).
All the c<lScs were re\'icwed by first and

------r\t-e:ln
1!cmol.!.ltlbin ("'nlidl)
Wl1itc Cell Coun1 ( j(fil
9
PLllekl count ( 10 /l)

author independently. On the basis of
morphology. cytochemistry and imtnunophenntyping,
third
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Table 3: FAB distribution of AML according to
a~e 2roup (n~ 116)
Fab Group < 15 Years n 1X) > 15 Years n o/o
MO
Ml
M2
M3

~

· M5 a

M5b
M6
M7
Total

·--~-

05 (23X)
01 (4.7)
06 (28.5)
00 (0)
07 (33.3)
00 (0)
01 (4.7)
0 I (4.7)
00 (0)
21 (\00)

The FAB distribution of AML has been
extensively studied in the past decades at national
9
and international levels. ' 12 - 1'J In table 4 the adult
results are compared with other series using fAB
system.
Most
published
data
indicate
the

04 (4.2)
09 (9.4)
29(305)
12 ( 12.6)
35 (36.8)
04(4.2)
02 (2.\)
00 (0)
00 (0)

predominance of M2 as a most common subtvpc_'J l-+11''1x Occurrence of this subtype is also co;lllll<;n after
1

primary malignancy? However, two studies from
Saudi Kingdom reported predominance of M4 and
MS ~ubtypcs. L\.1? Nakasc et a[ showed AML-M4 as
common subtype in Australian population compared
to Japanese, where AML-M2 is common. 11 Present
study also confirms M4 as the most common type
followed by M2. This is in concordance with the
previously published results from our institution by
1
Kakepoto ct ai. 'J
Many of the differences in AML ~ubtypcs
may be due to the subjectivity of morphologic
diagnosis together with variable nature of acute
myeloid
leukemia
subtypes,
with
no
real
demarcation. Some genetic
factors may be
responsible for a particular FAB subtype of AMLin
our population. Secondly most studies at national
level have small number of patients and probablv
\vith
underutilization of cytochemical .'\tain;.
Moreover these .<>tudies were not subjected to
immunophcnotyping that may be because of error in
diagnosis. The other reason for this di,.crcpancy may
be patients of different ethnic group and/or
geographical variation.
1
Auer rods were seen in 36 % of cases with
13
highest frequency in M3. Spence ct a[
reported
Aucr rods in 40.6(% of cases in their series. These
results are consit>tent with present study.
Male to female ratio in present study is
1.5:1, which is in concordance with national and
· t
·
I t d.
141(,172?
m ernattona s u tes. - · · The mean age (32
years) at presentation seems to be lower than the
expected mean age reported in western countries
11
where AML peaks in incidence after the 6( decade of
23
life. HO\vever, this is similar to mean age reported
17
16 19 24
in studies from Saudi Arabia
and Pakistan. " ·
The difference of mean age between present study
and western studies is probably due to different
geographical distribution.

DISCUSSION
With the introduction during the late 1960s and
1970s of increasingly effective therapy for acute
leukemias, it became necessary to determine
subgroups, which might require different treatment
approaches. In 1976 F AB system 4 of classification
\vas introduced, which was subsequently revised at
various times to improve concordancc. 5· 1'· 7 This
system provided structured criteria for the diagnosis
of various sub types of AML and is based mainly on
morphological and cytochemical features; for some
of the categories, immunophenotyping is necessary. 1L'J
Since than it has been \videly adopted nationally and
internationally for classification of acute Ieukemlas,
although ambiguities still give rise to confu::;ion and it
has been the subject of recent criticism. 111 So. in 1997
a revised WHO ~lassification of AML was Published
which included cytogenetic studie~ as wclJ. 11
However this classification is not practiced \Videly at
national level because of financial constraint.<;. The
clinical and biological significance is also claimed for
this sy~tcm which accounts for distinct prognostic
differences for various subtypes and their close
association
w·ith
chromosomal
abnormalities.
Although FAB propo~ab may be considered over
simplification, but they do serve to provide the
guidelines for both hematologists and non specialists
and facilitate quick, consistent diagnosis and
classification of these diseases. It is for these reasons
that FAB is still favourite and popular among
Pakistani hematologists.

Table 4: FAB Classification of AMLin various centers in adults
Author/ Year/ No of Cases
Swirsky et al '1986 (U.K) n• 619
Spence el a! · 1988 (KSA) n 121
Raina eta\ r:r\990 (Libya) n 54
Hassan eta!" 1993 (Pak) n 62
Chaudry ct al"'1993 (Pak) n 54
llarakat1 ct al ' 1998 (KSA) n 52
Khaltd1 ct a\ " 1998 (USA) n·-78
Kakeporo et al 2002 (Pak ) n 74
Arber et al 2003 (USA) n ?55
Present Study n 95

Moo;;,

Ml'X,

00
t.7
00
\.6
00
00
8.9
00
7.0

30
t.7
7
22.5
13
2
19.2
8.1
19.2
9.4

1.2

28

M2%
25
14.9
57
32.2
44.4
4

27.0
16
28.67
30.5

M3(X,
5
8.3
15
9.1
11.1
17
9.0
15
8.7
12.6

M4'Yo
23
57.8
\3
22.5
24
40
20.5
46
26.7
36.8

MS%
\3
13.2
4
8.6
3.7
33
11.5
9.5
4.8
6.3

M6'X.
2.4
\.7
4
1.6

3.7
00
2.6
00
2.5
00

M7%
00
()()
00
1.6
00
04
1.3
2.7
2.4

00
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CONCLUSION
10.

In conclu~ion the most common type observed m our
study wa~ Acute Myelornonocytic Leukemia (M4)
ftJIIowcd by Acute \llyelob!astic Leukemia with

II.

111aturation (M2). Although demographic features is

not the aim of our study but this is in accordance with
o!hcr n<ttional studies.
:\ multi-imtitutional study with large sample size

12

!i-nm nthcr urcas of Pakistan is needed to confirm our

J'indings. It IS de:;irable that more than one
experienced observer should examine the material
before <J final diagnosis i:; made. A full range of

13.

cytochemical
stains
ts
essential
with
imnumophenotyping studies where appropriate for

14

proper identification of the acute leukemias.
15
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